ACI\'s 14th National Conference on
Tuesday, July 17 to Wednesday, July 18, 2012
Omni Parker House, Boston, MA
The FDA recognizes that there have been “dramatic changes” in how clinical trials are conducted and monitored.
Modernize your company’s policies and protocols to place your company at the forefront of the quickly evolving clinical trials landscape.
In the last year, between the issuance of final and proposed regulations on clinical trials conduct and unprecedented government and public scrutiny of trials, structuring and conducting safe and compliant clinical trials has never been a more difficult task. Undoubtedly, there will be even more challenges and new demands on even the most seasoned clinical trials professionals in the months to come. In light of the complexity facing the clinical trials world, ACI’s 14th Advanced Forum on Clinical Trials provides a comprehensive forum for the key stakeholders — current and former government enforcers, top in-house counsel from sponsor biopharmaceutical and medical device companies, CROS, hospitals, universities, and research institutions — to unite and share best practices when structuring a safe and compliant clinical trials program which maximizes data integrity and human subject protection.
More is at stake than ever with record-breaking fines and criminal and civil liability.
The continued and steady stream of high-profile investigations into biopharmaceutical and device companies’ clinical studies data integrity makes it abundantly clear that it is imperative to have triage plans in place to weather the storm of criminal and civil liability stemming from clinical trial research.
Successful clinical trials are essential to a company’s pipeline and market share. Attendees of this event will:
Over the years, previous attendees have demanded even more in-depth information on the logistical and practical challenges of running a trial, so this year we are pleased to present two highly in-depth sessions run by practitioners in the trenches: The Nuts-and-Bolts of Structuring and Carrying Out Large Scale International Clinical Trials and Clinical Trials for Medical Device Companies.
Don’t hesitate- streamlined and safe clinical trials are crucial to the continued success of your company. Call 888-224-2480, fax your registration form to 877-927-1563 or register on-line at www.AmericanConference.com/ClinicalTrials to ensure that you have a spot among your peers at this summit of the leaders in the clinical trials industry.
- click image for pdf -
- Actions -
- Share -
Tue, Jul 17, 2012
Wed, Jul 18, 2012
Omni Parker House
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. Th is course is identified as nontransitional for the purposes of CLE accreditation.
ACI certifies that the activity has been approved for CLE credit by the New York State Continuing Legal Education Board in the amount of 15.0 hours, of which 1.0 will apply to Ethics. An additional 4.0 credit hours will apply to workshop A participation and 3.5 credit hours will apply to workshop B participation.
ACI certifies that this activity has been approved for CLE credit by the State Bar of California in the amount of 12.75 hours, of which 1.0 will apply to Ethics. An additional 3.5 credit hours will apply to workshop A participation and 3.0 credit hours will apply to workshop B participation.You are required to bring your state bar number to complete the appropriate state forms during the conference. CLE credits are processed in 4-8 weeks aft er a conference is held.
ACI has a dedicated team which processes requests for state approval. Please note that event accreditation varies by state and ACI will make every eff ort to process your request.Questions about CLE credits for your state? Visit our online CLE Help Center at www.americanconference.CLE